LEMAITRE VASCULAR INC (LMAT)

symbol lookup

Follow LMAT via My Validea and receive an email alert whenever any of our strategies changes its rating.

Get Started
Score: 100/100
Analysis based upon 4/19/2018 closing price.
Latest Close: $41.02 Market Cap ($ mil): $785 Sector: Healthcare Industry: Medical Equipment & Supplies Debt/Equity: 0.00 Shareholder Yield: N/A
PE Ratio: 49.0 Price/Sales: 7.8 Price/Book: 7.2 Yield: 0.7% Return on Equity: 17.0% Return on Capital: 26.0%
52 Week High: $41.25 52 Week Low: $24.95 Relative Strength: 88 LT EPS Growth: 45.3% LT Sales Growth: 12.1% EV/EBITDA: 29.54
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Report Card - Momentum Investor

Guru Criteria: Validea  
THIS QUARTER VS. SAME QUARTER LAST YEAR:PASS
ANNUAL EARNINGS GROWTH:PASS
EARNINGS CONSISTENCY:PASS
CURRENT PRICE LEVEL:PASS
4 MONTH S&P RELATIVE STRENGTH LINE:PASS
PRICE PERFORMANCE COMPARED TO ALL OTHER STOCKS:PASS
CONFIRM AT LEAST ONE OTHER LEADING STOCK IN THE INDUSTRY:PASS
LOOK FOR LEADING INDUSTRIES:PASS
DECREASING LONG-TERM DEBT/EQUITY:PASS
RETURN ON EQUITY:PASS
SHARES OUTSTANDING:PASS
INSIDER OWNERSHIP:PASS
INSTITUTIONAL OWNERSHIP:PASS

Detailed Analysis

Get a full analysis of LMAT using this and 11 other strategies of investment legends.

Start Your Free Trial